Company Filing History:
2 out of 1,323 
1 out of 832,891 Years Active: 2000-2001
Title: Debra M Meyer: Innovator in Monoclonal Antibody Research
Introduction
Debra M Meyer is a prominent inventor based in Wentzville, MO (US), known for her significant contributions to the field of monoclonal antibodies. With a total of three patents to her name, she has made remarkable strides in developing methods for treating integrin-mediated diseases.
Latest Patents
Her latest patents include innovative methods for using anti-αvβ3 integrin antibodies. These monoclonal antibodies recognize the α,β integrin receptor complex but do not significantly bind to α,β. This unique property allows them to be utilized in methods for treating α,β integrin-mediated diseases, such as tumor metastasis. Additionally, she has developed anti-αvβ3 integrin antibody antagonists that inhibit α,β integrin-mediated diseases, showcasing her expertise in this critical area of research.
Career Highlights
Throughout her career, Debra has worked with notable companies, including G.D. Searle & Company. Her work has significantly impacted the development of therapeutic strategies aimed at combating serious health conditions.
Collaborations
Debra has collaborated with esteemed colleagues, including Christopher P Carron and George A Nickols, further enhancing her research and innovation in the field.
Conclusion
Debra M Meyer stands out as a leading inventor in monoclonal antibody research, with her patents paving the way for advancements in treating integrin-mediated diseases. Her contributions continue to influence the scientific community and improve therapeutic options for patients.